VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q64679047  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000216.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q64679047‏
024 ‎‡a  0000-0003-0659-0139‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q64679047‏
100 0 ‎‡a  Lily Hui-Ching Wang‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Lily Hui-Ching Wang‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
400 0 ‎‡a  Lily Hui-Ching Wang‏ ‎‡c  investigador‏ ‎‡9  es‏
400 0 ‎‡a  Lily Hui-Ching Wang‏ ‎‡c  investigador/a‏ ‎‡9  ast‏
670 ‎‡a  Author's Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.‏
670 ‎‡a  Author's Aerobic glycolysis supports hepatitis B virus protein synthesis through interaction between viral surface antigen and pyruvate kinase isoform M2‏
670 ‎‡a  Author's Centromere DNA decatenation depends on cohesin removal and is required for mammalian cell division‏
670 ‎‡a  Author's Compliance with risk management plan recommendations on laboratory monitoring of antitumor necrosis factor-α therapy in clinical practice‏
670 ‎‡a  Author's Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions.‏
670 ‎‡a  Author's Development and Evaluation of Vero Cell-Derived Master Donor Viruses for Influenza Pandemic Preparedness‏
670 ‎‡a  Author's Erratum to: PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma‏
670 ‎‡a  Author's Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis.‏
670 ‎‡a  Author's Heparin-Promoted Cellular Uptake of the Cell-Penetrating Glycosaminoglycan Binding Peptide, GBPECP, Depends on a Single Tryptophan.‏
670 ‎‡a  Author's Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production‏
670 ‎‡a  Author's Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis‏
670 ‎‡a  Author's Incidence, Outcomes, and Risk Factors of Community-Acquired and Hospital-Acquired Acute Kidney Injury: A Retrospective Cohort Study‏
670 ‎‡a  Author's Intrahepatic HBV large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.‏
670 ‎‡a  Author's Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method‏
670 ‎‡a  Author's Microtubule depolymerization activates the Epstein-Barr virus lytic cycle through protein kinase C pathways in nasopharyngeal carcinoma cells‏
670 ‎‡a  Author's Pathogenesis of virus-associated human cancers: Epstein-Barr virus and hepatitis B virus as two examples‏
670 ‎‡a  Author's Persistence of DNA threads in human anaphase cells suggests late completion of sister chromatid decatenation‏
670 ‎‡a  Author's PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.‏
670 ‎‡a  Author's PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis‏
670 ‎‡a  Author's Re-examination of siRNA specificity questions role of PICH and Tao1 in the spindle checkpoint and identifies Mad2 as a sensitive target for small RNAs‏
670 ‎‡a  Author's SH2B1 and IRSp53 proteins promote the formation of dendrites and dendritic branches‏
670 ‎‡a  Author's The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.‏
670 ‎‡a  Author's The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities.‏
909 ‎‡a  (orcid) 0000000306590139‏ ‎‡9  1‏
919 ‎‡a  aerobicglycolysissupportshepatitisbvirusproteinsynthesisthroughinteractionbetweenviralsurfaceantigenandpyruvatekinaseisoformm2‏ ‎‡A  Aerobic glycolysis supports hepatitis B virus protein synthesis through interaction between viral surface antigen and pyruvate kinase isoform M2‏ ‎‡9  1‏
919 ‎‡a  aberrantcyclinaexpressionandcentrosomeoverduplicationinducedbyhepatitisbviruspres2mutantsanditsimplicationinhepatocarcinogenesis‏ ‎‡A  Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.‏ ‎‡9  1‏
919 ‎‡a  involvementofmct1oncoproteinininducingmitoticcatastropheandnuclearabnormalities‏ ‎‡A  The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities.‏ ‎‡9  1‏
919 ‎‡a  emergingroleofhepatitisbviruspres2deletionmutantproteinsinhbvtumorigenesis‏ ‎‡A  The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.‏ ‎‡9  1‏
919 ‎‡a  sh2b1andirsp53proteinspromotetheformationofdendritesanddendriticbranches‏ ‎‡A  SH2B1 and IRSp53 proteins promote the formation of dendrites and dendritic branches‏ ‎‡9  1‏
919 ‎‡a  reexaminationofsirnaspecificityquestionsroleofpichandtao1inthespindlecheckpointandidentifiesmad2asasensitivetargetforsmallrnas‏ ‎‡A  Re-examination of siRNA specificity questions role of PICH and Tao1 in the spindle checkpoint and identifies Mad2 as a sensitive target for small RNAs‏ ‎‡9  1‏
919 ‎‡a  pichpromotessisterchromatiddisjunctionandcooperateswithtopoisomerase2inmitosis‏ ‎‡A  PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis‏ ‎‡9  1‏
919 ‎‡a  pgrmc1contributestodoxorubicininducedchemoresistanceinmessauterinesarcoma‏ ‎‡A  PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.‏ ‎‡9  1‏
919 ‎‡a  persistenceofdnathreadsinhumananaphasecellssuggestslatecompletionofsisterchromatiddecatenation‏ ‎‡A  Persistence of DNA threads in human anaphase cells suggests late completion of sister chromatid decatenation‏ ‎‡9  1‏
919 ‎‡a  pathogenesisofvirusassociatedhumancancersepsteinbarrvirusandhepatitisbvirusas2examples‏ ‎‡A  Pathogenesis of virus-associated human cancers: Epstein-Barr virus and hepatitis B virus as two examples‏ ‎‡9  1‏
919 ‎‡a  microtubuledepolymerizationactivatestheepsteinbarrviruslyticcyclethroughproteinkinase100pathwaysinnasopharyngealcarcinomacells‏ ‎‡A  Microtubule depolymerization activates the Epstein-Barr virus lytic cycle through protein kinase C pathways in nasopharyngeal carcinoma cells‏ ‎‡9  1‏
919 ‎‡a  investigatingcoresignalingpathwaysofhepatitisbviruspathogenesisforbiomarkersidentificationanddrugdiscoveryviasystemsbiologyanddeeplearningmethod‏ ‎‡A  Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method‏ ‎‡9  1‏
919 ‎‡a  intrahepatichbvlargesurfaceantigeninduceshepatocytehyperploidyviafailureofcytokinesis‏ ‎‡A  Intrahepatic HBV large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.‏ ‎‡9  1‏
919 ‎‡a  incidenceoutcomesandriskfactorsofcommunityacquiredandhospitalacquiredacutekidneyinjuryaretrospectivecohortstudy‏ ‎‡A  Incidence, Outcomes, and Risk Factors of Community-Acquired and Hospital-Acquired Acute Kidney Injury: A Retrospective Cohort Study‏ ‎‡9  1‏
919 ‎‡a  hepatitisbviruspres2mutantlargesurfaceproteininhibitsdnadoublestrandbreakrepairandleadstogenomeinstabilityinhepatocarcinogenesis‏ ‎‡A  Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis‏ ‎‡9  1‏
919 ‎‡a  hepaticexpressionofhcvrnadependentrnapolymerasetriggersinnateimmunesignalingandcytokineproduction‏ ‎‡A  Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production‏ ‎‡9  1‏
919 ‎‡a  heparinpromotedcellularuptakeofthecellpenetratingglycosaminoglycanbindingpeptidegbpecpdependsonasingletryptophan‏ ‎‡A  Heparin-Promoted Cellular Uptake of the Cell-Penetrating Glycosaminoglycan Binding Peptide, GBPECP, Depends on a Single Tryptophan.‏ ‎‡9  1‏
919 ‎‡a  groundglasshepatocytescoexpressinghepatitisbvirus10proteinandsurfaceantigensexhibitenhancedoncogeniceffectsandtumorigenesis‏ ‎‡A  Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis.‏ ‎‡9  1‏
919 ‎‡a  erratumtopgrmc1contributestodoxorubicininducedchemoresistanceinmessauterinesarcoma‏ ‎‡A  Erratum to: PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma‏ ‎‡9  1‏
919 ‎‡a  developmentandevaluationofverocellderivedmasterdonorvirusesforinfluenzapandemicpreparedness‏ ‎‡A  Development and Evaluation of Vero Cell-Derived Master Donor Viruses for Influenza Pandemic Preparedness‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessanalysisforgenotypingbeforeallopurinoltreatmenttopreventseverecutaneousadversedrugreactions‏ ‎‡A  Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions.‏ ‎‡9  1‏
919 ‎‡a  compliancewithriskmanagementplanrecommendationsonlaboratorymonitoringofantitumornecrosisfactorαtherapyinclinicalpractice‏ ‎‡A  Compliance with risk management plan recommendations on laboratory monitoring of antitumor necrosis factor-α therapy in clinical practice‏ ‎‡9  1‏
919 ‎‡a  centromerednadecatenationdependsoncohesinremovalandisrequiredformammaliancelldivision‏ ‎‡A  Centromere DNA decatenation depends on cohesin removal and is required for mammalian cell division‏ ‎‡9  1‏
996 ‎‡2  DNB|1312283327‏
996 ‎‡2  DNB|173778917‏
996 ‎‡2  LC|n 2017005513‏
996 ‎‡2  ISNI|0000000044872477‏
996 ‎‡2  NSK|000754545‏
996 ‎‡2  ISNI|0000000045439499‏
996 ‎‡2  DNB|1028577079‏
996 ‎‡2  DNB|1340255367‏
996 ‎‡2  SUDOC|162018053‏
996 ‎‡2  LC|n 85064938‏
996 ‎‡2  CYT|AC000609509‏
996 ‎‡2  LC|n 2004101983‏
996 ‎‡2  DNB|1339056046‏
996 ‎‡2  RERO|A018080334‏
996 ‎‡2  DNB|1279742925‏
996 ‎‡2  NSK|000526804‏
996 ‎‡2  LC|n 2015004559‏
996 ‎‡2  NII|DA10450819‏
996 ‎‡2  SUDOC|074690914‏
996 ‎‡2  LC|no2005021048‏
996 ‎‡2  NTA|364154152‏
996 ‎‡2  NYNYRILM|336852‏
996 ‎‡2  LC|no2020046478‏
996 ‎‡2  SUDOC|226109755‏
996 ‎‡2  DNB|122244576X‏
996 ‎‡2  NUKAT|n 2020180024‏
996 ‎‡2  BNE|XX6347445‏
996 ‎‡2  DNB|1152338943‏
996 ‎‡2  PTBNP|41206‏
996 ‎‡2  SUDOC|281061580‏
996 ‎‡2  DNB|1247288374‏
996 ‎‡2  LC|no2009203446‏
996 ‎‡2  NSK|000676290‏
996 ‎‡2  LC|no2009203445‏
996 ‎‡2  PLWABN|9810815888205606‏
996 ‎‡2  LC|no2016163537‏
996 ‎‡2  DNB|1197147144‏
996 ‎‡2  PLWABN|9811552473905606‏
996 ‎‡2  ISNI|0000000028390443‏
996 ‎‡2  DNB|136609961‏
996 ‎‡2  DNB|1272801942‏
996 ‎‡2  LC|no2021096091‏
996 ‎‡2  ISNI|0000000073376149‏
996 ‎‡2  LC|n 2021005738‏
996 ‎‡2  DNB|1051298180‏
996 ‎‡2  LC|no2017155084‏
996 ‎‡2  DNB|1065204221‏
996 ‎‡2  NUKAT|n 2019186145‏
996 ‎‡2  LC|no2008056349‏
996 ‎‡2  DNB|1244259705‏
996 ‎‡2  PLWABN|9811522047805606‏
996 ‎‡2  DNB|143380125‏
996 ‎‡2  NUKAT|n 2014061020‏
996 ‎‡2  DNB|1060262975‏
996 ‎‡2  NTA|309531292‏
996 ‎‡2  SUDOC|233544070‏
996 ‎‡2  ISNI|0000000395707422‏
996 ‎‡2  LC|n 2011018492‏
996 ‎‡2  ISNI|0000000388284740‏
996 ‎‡2  LC|n 2024060195‏
996 ‎‡2  ISNI|0000000118061360‏
996 ‎‡2  DNB|1235545970‏
996 ‎‡2  CAOONL|ncf11530748‏
996 ‎‡2  ISNI|0000000495832044‏
996 ‎‡2  NTA|364154683‏
996 ‎‡2  ISNI|0000000069723267‏
996 ‎‡2  DNB|1335880232‏
996 ‎‡2  RERO|A003957507‏
996 ‎‡2  DNB|1249702534‏
996 ‎‡2  NSK|000337340‏
996 ‎‡2  CYT|AC000497619‏
996 ‎‡2  LC|n 78035431‏
996 ‎‡2  BIBSYS|7064331‏
996 ‎‡2  LC|n 2015019663‏
996 ‎‡2  DNB|1216843066‏
996 ‎‡2  LC|n 92107826‏
996 ‎‡2  DNB|1089423969‏
996 ‎‡2  NTA|340412437‏
996 ‎‡2  LC|no2006084869‏
996 ‎‡2  DNB|1151741205‏
996 ‎‡2  PLWABN|9811797820105606‏
996 ‎‡2  LC|n 2022013512‏
996 ‎‡2  DNB|1322061327‏
996 ‎‡2  DNB|104821009X‏
996 ‎‡2  DNB|12177824X‏
996 ‎‡2  ISNI|0000000077348233‏
996 ‎‡2  LC|no2004003619‏
996 ‎‡2  BNF|16190196‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏